. Jacobson-dl, . Peralta-l, G. Farmer-m, W. Nm, . Tc et al., Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents, Int J Gynaecol Obstet, vol.66, pp.7-17, 1999.

. Kurman-rj, Anatomy and histology of the cervix. In: Blaustein's Pathology of the Female Genital Tract, 2002.

G. M. Lauer and W. Bd, Hepatitis C virus infection, N Engl J Med, vol.345, pp.41-52, 2001.

. Levine-am, AIDS-related malignancies: the emerging epidemic, J Natl Cancer Inst, vol.85, pp.1382-1397, 1993.

B. Lorenzo-o, . Cm, . Bautista-soriano-c, R. Halpern-m, H. N. Perez-then-e et al., Progress towards elimination of HIV mother-to-child transmission in the Dominican Republic from, Infect Dis Obstet Gynecol, p.543916, 1999.

. Lukac-dm and . Yuan-y, Reactivation and lytic replication of KSHV, 2007.

C. Manns-a, . Fr, . Falk-rt, J. Hanchard-b, . Es et al., Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study Group, Lancet, vol.342, pp.1447-1450, 1993.

K. Mbulaiteye-sm, . Et, H. Wabinga, . Parkin-dm, . Virgo-p et al., Spectrum of cancers among HIVinfected persons in Africa: the Uganda AIDS-Cancer Registry Match Study, Int J Cancer, vol.118, pp.985-990, 2006.

, 1: Geographical patterns of KS, NHL and cervical cancer associated with HIV infection in five African populations 105

P. Fritz-a, J. A. Jm, . Shanmugaratnam-k, . Sobin-l, E. T. Parkin-dm et al., International Classification of Diseases for, Oncology. WHO

G. Jp, G. , P. Jm, and . Moreno-otero-r, PREVALENCE of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and metaanalysis, Gastroenterology, vol.125, issue.6, pp.1723-1732, 2003.

J. J. Goedert, The epidemiology of acquired immunodeficiency syndrome malignancies, Semin Oncol, vol.27, issue.4, pp.390-401, 2000.

. Iarc-working, . On, . Evaluation, . Carcinogenic, . To et al., Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses, IARC, 1996.

. Iarc-working, . On, . Evaluation, . Carcinogenic, . To et al., Hormonal Contraception and Post-menopausal Hormonal Therapy, vol.72, 1999.

. Iarc-working, . On, . Evaluation, . Carcinogenic, . To et al., Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy, IARC/WHO. 2013. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC), vol.91, 1997.

J. Jy, L. W. Shao-rx, C. Weinberg-e, . Wj, and . Tsai-wl, HIV infection increases HCV-induced hepatocyte apoptosis, J Hepatol, vol.54, issue.4, pp.612-620, 2010.

K. Sp, R. Sa, C. F. , B. Jj, H. Fb et al., Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males, Blood, vol.66, issue.3, pp.655-659, 1985.

. Kilani-b, . Ammari-l, . Marrakchi-c, . Letaief-a, M. Chakroun et al., Seroepidemiology of HCV-HIV coinfection in Tunisia, Tunis Med, vol.85, issue.2, pp.121-123, 2007.

V. Madhava, C. Burgess, and E. Drucker, Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa, Lancet Infect Dis, vol.2, issue.5, pp.293-302, 2002.

. Mahomva-a, . Greby-s, . Dube-s, . Mugurungi-o, J. Hargrove et al., HIV prevalence and trends from data in Zimbabwe, Sex Transm Infect, 1997.

, 1: Geographical patterns of KS, NHL and cervical cancer associated with HIV infection in five African populations 107

. Parkin-dm, W. Nambooze-s, and W. Hr, Changing cancer incidence in Kampala, Int J Cancer, vol.126, issue.5, pp.1187-1195, 1991.

. Percy-c, . Van-holten-m, and . Muir-c, International Classification of Diseases for Oncology, 2010.

W. Pfeiffer-rm, . Wa, W. D. Mbisa-g, G. Jj, and . De-tg, Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology, Ann Epidemiol, vol.20, issue.12, pp.958-963, 2010.

. Polesel-j, . Franceschi-s, C. E. Suligoi-b, . Falcini-f, and . Guzzinati-s, Cancer incidence in people with AIDS in Italy, Int J Cancer, vol.127, issue.6, pp.1437-1445, 2010.

, Rabkin CS Epidemiology of AIDS-related malignancies, Curr Opin Oncol, vol.6, issue.5, p.492, 1994.

R. Mv, B. Sh, J. Ra, D. Sl, . Bass-dc et al., Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia, Blood, vol.81, issue.7, pp.1889-1897, 1993.

S. Sari-z-;-pdf, J. Aj, E. Boidin-e, . Dk, . Thouillot-f et al., Epidemiological and biological caracteristics of hepatitis C in Algeria.Association of Algerian Internist (AILA) 2009. Algiers, Algeria, PLoS One, 2009.

A. Singal-ak and . Bs, Management of hepatitis C virus infection in HIV/HCV coinfected patients: clinical review, World J Gastroenterol, vol.15, issue.30, pp.3713-3724, 2009.

. Sissolak-g and . Mayaud-p, AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa, Trop Med Int Health, vol.10, issue.10, pp.981-992, 2005.

. Triki-h, B. Said-n, A. A. Sa, . Ben-af, and . Bouguerra-a, Seroepidemiology of hepatitis B, C and delta viruses in Tunisia, Trans R Soc Trop Med Hyg, vol.91, issue.1, pp.11-14, 1997.

W. Unaids, Report on the global AIDS epidemic. Geneva, 2008.

, 2: KS trends in Uganda and Zimbabwe: a sustained decline in incidence, p.131

. Fenton-l, Preventing HIV/AIDS through poverty reduction: the only sustainable solution, Lancet, vol.364, pp.1186-1187, 2004.

L. M. Franceschi-s, C. Gm, R. M. , L. F. Maspoli-m, . Bouchardy-c et al., Changing patterns of cancer incidence in the early-and late-HAART periods: the Swiss HIV Cohort Study, Br J Cancer, vol.103, pp.416-422, 2010.

P. Fritz-a, J. A. Jm, . Shanmugaratnam-k, . Sobin-l, W. Parkin-dm et al., International Classification of Diseases for Oncology, 2000.

H. Green-ec, . Dt, H. Nantulya-v, and . Ja, Uganda's HIV prevention success: the role of sexual behavior change and the national response, AIDS Behav, vol.10, pp.335-346, 2006.

. Halperin-dt, . Mugurungi-o, . Hallett-tb, . Muchini-b, . Campbell-b et al., A surprising prevention success: why did the HIV epidemic decline in Zimbabwe, PLoS Med, vol.8, p.1000414, 2011.

. Hiza-pr, International co-operation in the national AIDS control program, Proceeding of the First International Conference on the Global Impact of AIDS, pp.233-239, 2010.

. International-agency-for, . Research, and . Cancer, Kaposi's sarcoma herpesvirus/human herpes virus 8.Lyon (France): IARC, 375-492. International Programs Center, Population Division U. S. Census Bureau. HIV/AIDS Surveillance Data Base: Uganda. International Programs Center, 1997.

. Mosam-a, U. Shaik-f, . Ts, F. Esterhuizen-t, S. Gh et al., A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa, J Acquir Immune Defic Syndr, vol.60, pp.150-157, 2012.

U. Mosam-a, . Ts, . Shaik-f, H. Carrara, and A. Coovadia-h, An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in, Int J STD AIDS, vol.22, pp.671-673, 2011.

O. Si, Towards a national AIDS-control program in Uganda, West J Med, vol.147, pp.726-729, 1987.

. Parkin-dm, A. P. Vizcaino, . Skinner-me, and . Ndhlovu-a, Cancer patterns and risk factors in the African population of southwestern Zimbabwe, Cancer Epidemiol Biomarkers Prev, vol.3, pp.537-547, 1963.

H. Hiv, KS trends in Uganda and Zimbabwe: a sustained decline in incidence, Africa and their impact on cancer Chapter, issue.2, p.132

. Parkin-dm, H. Wabinga, and W. Nambooze-s, AIDS-related cancers in Africa: maturation of the epidemic in Uganda, AIDS, vol.13, pp.2563-2570, 1999.

W. Pfeiffer-rm, . Wa, W. D. Mbisa-g, G. Jj, D. E. Tg et al., Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology, Ann Epidemiol, vol.20, pp.958-963, 2010.

M. V. Safai-b, G. G. , and B. E. Good-ra, Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications, Cancer, vol.45, pp.1472-1479, 1980.

. Sanders-cj, Kaposi's sarcoma in retrospect, Genitourin Med, vol.73, pp.571-574, 1997.

W. D. Seaberg-ec, C. Martinez-maza-o, K. L. Js, M. Tang-y, J. Jb et al., Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era, Cancer, vol.116, pp.5507-5516, 1984.

M. Serwadda-d, . Rd, . Sewankambo-nk, C. Lwegaba-a, K. Jw et al., Slim disease: a new disease in Uganda and its association with HTLV-III infection, Lancet, vol.2, pp.849-852, 1985.

H. Shelton-jd, . Dt, . Nantulya-v, G. Potts-m, . Hd et al., Partner reduction is crucial for balanced "ABC" approach to HIV prevention, BMJ, vol.328, pp.891-893, 2004.

. Shiels-ms, H. Pfeiffer-rm, L. J. Hi, G. Jj, M. Lm et al., Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, JAMA, vol.305, pp.1450-1459, 1980.

. ?idàk-z, Rectangular confidence region for themeans of multivariate normal distributions, Journal of the American Sta-tistical Association, vol.62, pp.626-633, 1967.

S. Singh, J. E. Darroch, A. A. Bankole, and . In-uganda, The Roles of Abstinence, Monogamy and Condom Use in HIV Decline, Occasional Report, issue.9, 2003.

. Sissolak-g and . Mayaud-p, AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa, Trop Med Int Health, vol.10, pp.981-992, 2005.

, Statistical Methodology and Applications Branch and Data Modeling Branch, 2011.

, Joinpoint Regression Program . National Cancer Institute, 2008.

, 2: KS trends in Uganda and Zimbabwe: a sustained decline in incidence, p.133

. Stoneburner-rl and . Low-beer-d, Population-level HIV declines and behavioral risk avoidance in Uganda, Science, vol.304, pp.714-718, 2004.

T. Jf, T. Ac, Z. Vogel-cl, K. Jl, and . Sk, Kaposi's sarcoma in Uganda: a clinico-pathological study, Int J Cancer, vol.8, pp.122-135, 1971.

. Thijs-a, Kaposi's angiosarcomatosis in the Belgian Congo & Ruanda-Urundi, 1957.

, Ann Soc Belg Med Trop, vol.37, pp.295-308, 1920.

W. Unaids, Report on the global AIDS epidemic . UNAIDS WHO, 2008.

, UNAIDS WHO. UNAIDS report on the global AIDS epidemic 2010. WHO. 2010. Geneva, Swizerland, 2011.

. Unaids/who, UNAIDS World AIDS Day Report, 2011.

. Vanni-t, . Sprinz-e, S. Machado-mw, F. Rc, . Ba et al., Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives, Cancer Treat Rev, vol.32, pp.445-455, 2006.

. Wabinga-h, A. M. Nambooze-s, and . Uganda, Kampala Cancer Registry (KCR)

, Kampala Cancer Registry, 2010.

S. Geneva, . References, M. Touaibia-r, A. , and B. M. Rapport, Rapport de Situation National à l'Intention de l'UNGASS sur le Suivi de la Déclaration d'Engagement de la Session Extraordinaire de l'Assemblée Générale des Nations Unies (UNGASS) sur le VIH / SIDA, 2006.

, 5: A case of very late stage of HIV/AIDS at diagnosis in north-eastern Algeria, UNAIDS/WHO. Chapter, 2011.

. Aidaoui-m, . Bouzbid-s, and . Laouar-m, Seroprevalence of HIV infection in pregnant women in the Annaba region (Algeria), Rev Epidemiol Sante Publique, vol.56, pp.261-266, 2008.

O. Clyne-b and . Js, The C-reactive protein, J Emerg Med, vol.17, pp.1019-1025, 1999.

C. Prevention, Guide national de prise en charge thérapeutique de l'infection VIH/ sida et des infections opportunistes de l'adulte et de l'enfant, 2010.

. Davenport-j, Macrocytic anemia, Am Fam Physician, vol.53, pp.155-162, 1996.

. Kaptan-k, U. Beyan-c, . Au, A. Cetin-t, . Gulsen-m et al., Helicobacter pylori--is it a novel causative agent in Vitamin B12 deficiency?, Arch Intern Med, vol.160, pp.1349-1353, 2000.

. Moulignier-a, HIV and the central nervous system, Rev Neurol, vol.162, pp.22-42, 2006.

, Regional report on AIDS, 2011.

. Unaids/who, . World, and . Day, Co-occurrence of B-cell NHL and HCV in Algerian patients, vol.5, 2011.

. Ayed-z, . Houinato-d, M. Hocine, and D. F. Ranger-rogez-s, Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria, Bull Soc Pathol Exot, vol.88, pp.225-228, 1995.

. Bensalem-a, . Soltani-m, . Hihi-n, . Mostefaoui-f, . Dahmani-o et al., Prevalence of Hepatitis B and C in Algerian Center of Dialysis, p.4

, Journee Nationale d'Hygiene Hospitaliere et de Lutte Contre les Infections associees aux soins. 26-5-2011, pp.26-31

. Berkane-s, Etude prospective anatomo-clinique des hepatites chroniques d'origine virale de l'adulte, pp.18-24

M. L. Bouhidel, Registre du cancer de la wilaya de Batna de, 2008.

. Bouvard-v, . Baan-r, . Straif-k, . Grosse-y, E. L. Secretan-b et al., A review of human carcinogens--Part B: biological agents, Lancet Oncol, vol.10, pp.321-322, 2009.

. Dal-ml and . Franceschi-s, Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies, Cancer Epidemiol Biomarkers Prev, vol.15, pp.2078-2085, 2006.

. Siemens and . Versan, HCV genotype assay 2.0 (LiPA), 2011.

. Zemouli-n, . Gourari-s, . Ousser-f, H. Ziane, . Djennane-f et al., Public Hospital of Bologhine Ibn Ziri Hammamet Bainem, Experience of Mostapha Teaching Hospital. La 4eme Journee Nationale d'Hygiene Hospitaliere et de Lutte Contre les Infections Associees aux Soins. 26-5-2011, pp.26-31

T. Egypt, Z. Algeria, . Uganda, and . Bouvard, which is an AIDS-related cancer, was the highest in both sexes in Egypt, where the reported HIV/AIDS prevalence was very low. Several etiological viruses are responsible as the cause of NHL. HCV infection, recently linked to NHL, which has been related to national anti-schistosomal campaigns using parenteral therapy between the 1950s and the 1980s, 1996.

. Bouhidel, 10 to 26 cases, without any changes in screening or care access. The prevalence of HCV infection was 5.6% (2/36) in these NHL patients and 7.1% (2/28) among those with B-cell NHL (Figure 23), Algeria, another country with low HIV/AIDS prevalence, NHL incidence has increased since, 1995.

. Coppola, HCV infection may partly explain the emergence of NHL in Algeria, especially among patients with a high risk of nosocomial HCV infection. NHL patients with HCV infection in the haematology service of the CHU of Annaba were treated with immunochemotherapy. several reports have shown that rituximab-based chemotherapy for NHL can increase HCV RNA levels and may aggravate hepatic lesions in onco-haematological patients, although the aggravation of hepatic lesions is less frequent and less severe than in HBV-infected subjects, eastern Algeria (Batna region), HCV-positive patients with NHL were more likely to be elderly women with a high risk of nosocomial exposure to HCV (Figure 22), 2011.

, HIV and HCV infections in Africa and their impact on cancer General discussion 179

, Disease pathway: Co-occurrence of B-cell non-Hodgkin lymphoma and chronic hepatitis C virus infection HCV infection between, Figure, vol.23, 2009.

, ? Genotype 1b ? No liver complications Risk factors in all these HCV

, Constantine sur l'infection VIH/SIDA. Vth National Days of Infectious Disease Prevention, 2011.

. Abdennour-d, Niveau de connaissance et attitudes concernant le VIH/SIDA en milieu estudiantin. Vth National Days of Infectious Disease Prevention, 2011.

A. Lj, . Hilmi-n, . Mumtaz-g, A. Benkirane-m, . Fa et al., Epidemiology of HIV infection in the Middle East and North Africa, AIDS, vol.24, pp.5-23, 2010.

A. Ait-mohand-a, . Belamri-s, . Boughofallah-a, . Boutekdjiret-l, . Fourar-d et al., Projet TAHINA (Contrat n° ICA3-CT 2002-10011), pp.28-40, 2002.

. Atek-m, Y. Laid, . Mezimech-m, L. Boutekdjiret, and L. H. , L'obésité chez l'adule de 35 à 70 ans en Algérie. Projet Tahina: Transition épidémiologique et système de santé (Contrat n° ICA3-CT-2002-10011), 2010.

. Benabdellah-a, C. Abderrahim, S. Touati, and M. Labdouni,

, Hepatitis c virus genotypes in Algeria: the experience of CHU of Oran, 15th Annual Meeting of the European Society for Clinical Virology, 2012.

. Binagwaho-a, . Wagner-cm, . Gatera-m, C. Karema, N. Ct et al., , 2012.

, HIV and HCV infections in Africa and their impact on cancer General discussion 192

. Boneberger-a, . Ruckinger-s, . Guthold-r, L. Kann, and R. L. , HIV/AIDS related knowledge among school-going adolescents from the Middle East and North Africa, Sex Health, vol.9, pp.196-198, 2012.

. Bouhidel-ml, Registre du cancer de la Wilaya de Batna de, pp.14-16, 2000.

. Bouhidel-ml, Registre du cancer de la Wilaya de Batna de, 2007.

. Bouhidel-ml, . Bouhidel-a, . Saidi-m, and . Khadraoui-h, Registre du cancer de la Wilaya de Batna, 1995.

. Bouvard-v, . Baan-r, . Straif-k, . Grosse-y, . Secretan-b et al., A review of human carcinogens--Part B: biological agents, Lancet Oncol, vol.10, pp.321-322, 2009.

. Brinkhof-mw, . Boulle-a, M. E. Weigel-r, . Mathers-c, . Orrell-c et al.,

F. and P. M. Egger-m, Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality, PLoS Med, vol.6, p.1000066, 2009.

A. Chamberlain-rw, T. Nj, S. P. La, and E. Rm, The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa, Biochem Biophys Res Commun, vol.236, pp.44-49, 1997.

. Coppola-n, . Pisaturo-m, . Guastafierro-s, . Tonziello-g, . Sica-a et al., Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy, Dig Liver Dis. General discussion, p.193, 2011.

R. Cornberg-m, A. Ha, . Bernasconi-e, M. Buti, C. C. Dalgard-o et al.,

S. , M. P. Marinho-rt, . Pol-s, . Poynard-t, . Puoti-m et al., A systematic review of hepatitis C virus epidemiology in, 2011.

C. Europe and I. , Liver Int, vol.31, issue.2, pp.30-60

C. Kd, E. Loffredo-ca, . Sa, A. Mokhtar-n, and F. Strickland-gt, Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt, Int J Epidemiol, vol.33, pp.1034-1039, 2004.

D. Ma, C. Faris-r, . Jd, . Rao-mr, and . Edelman-r, High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile Delta: a pilot study, Am J Trop Med Hyg, vol.54, pp.554-558, 1996.

D. Ma and D. Aa, Hepatitis C virus in Arab world: a state of concern, ScientificWorldJournal, p.719494, 2012.

J. Ferlay, S. Hr, . Bray-f, . Forman-d, C. Mathers et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int J Cancer, vol.127, pp.2893-2917, 2008.

M. Frank-c, . Mk, . Strickland-gt, D. Lavanchy, and A. Rr,

E. L. Ls, B. Kt, . Ly-ohn, . Es, . Anwar-w et al., The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, Lancet, vol.355, pp.887-891, 2000.

. Gavi-alliance, GAVI funds vaccines to protect girls against cervical cancer. Gavi Alliance, 2013.

G. Jj, M. Jn, B. Jl, M. Ps, and Y. Jd, , 2011.

H. Green-ec, . Dt, H. Nantulya-v, and . Ja, Uganda's HIV prevention success: the role of sexual behavior change and the national response, AIDS Behav, vol.10, pp.335-346, 2006.

G. Gregson-s, N. Gp, H. Ca, L. Tb, M. Jj et al., HIV decline associated with behavior change in eastern Zimbabwe, Science, vol.311, pp.664-666, 2006.

. Halperin-dt, . Mugurungi-o, . Hallett-tb, . Muchini-b, . Campbell-b et al., A surprising prevention success: why did the HIV epidemic decline in Zimbabwe, PLoS Med, vol.8, p.1000414, 2011.

W. Hassan-zm and . Ma, Knowledge and attitudes of Jordanian nurses towards patients with HIV/AIDS: findings from a nationwide survey, Issues Ment Health Nurs, vol.32, pp.774-784, 2011.

. Iarc-working, . On, . Evaluation, . Carcinogenic, . To et al., Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy, vol.91, 2007.

. Institut-pasteur-d'algerie, Relevé des cas de sida et séropositifs de 1985 au 30 juin, 2009.

N. Kamal-sm and . Ia, Hepatitis C genotype 4: What we know and what we don't yet know, Hepatology, vol.47, p.195, 2008.

. Kobeissi-l, K. El-kak-fh, and . Khoshnood-k, HIV/AIDS-Related Knowledge and Its Association With Socioeconomic Status Among Women: Results of Lebanese Survey for Family Health (PAPFAM) 2004, Asia Pac J Public Health, 2011.

C. Kuiken and . Simmonds-p, Nomenclature and numbering of the hepatitis C virus, 2009.

, Methods Mol Biol, vol.510, pp.33-53

. Lavanchy-d, Evolving epidemiology of hepatitis C virus, Clin Microbiol Infect, vol.17, pp.107-115, 2011.

. Madhava-v, . Burgess-c, and . Drucker-e, Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa, Lancet Infect Dis, vol.2, pp.293-302, 2002.

M. Le, D. Tsu-v, . Sl, H. Cubie, and W. Sa,

, Human papillomavirus vaccine introduction--the first five years, Vaccine, vol.30, 2012.

M. Hk, J. Groeger, F. Ad, and W. St, Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence, Hepatology, 2012.

M. Muwonge-r, F. Mg, D. Ap, F. Jb, . Mr et al., Visual screening for early detection of cervical neoplasia in Angola, Int J Gynaecol Obstet, vol.111, pp.68-72, 2010.

M. Muwonge-r, . Cg, . Keita-n, . Dolo-a, H. Nouhou et al., Performance of colposcopy in five sub-Saharan African countries, BJOG, vol.116, pp.829-837, 2009.

. Ngoma-t, . Muwonge-r, J. Mwaiselage, J. Kawegere, . Bukori-p et al., Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania, Int J Gynaecol Obstet, vol.109, pp.100-104, 2010.

, HIV and HCV infections in Africa and their impact on cancer General discussion 196

S. Nooka-a, . Pj, . Sinha-r, S. Lonial, and . Flowers-cr, Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: A case report and review of literature, Clin Lymphoma Myeloma Leuk, 2011.

O. National and . Statistiques, Collections statistiques. Office National des Statistiques, 2012.

. Pampel-f, Tobacco use in sub-Sahara Africa: estimates from the demographic health surveys, Soc Sci Med, vol.66, pp.1772-1783, 2008.

. Parkin-dm, J. Ferlay, H. , S. F. , T. Jo et al., Cancer in Africa, 2003.

J. A. Salomon, W. H. , F. Mk, F. Vos-t, L. Ad et al.,

, Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study, Lancet, vol.380, pp.2144-2162, 2010.

. Sankaranarayanan-r, W. Basu-p, . Rs, . Mahe-c, M. Keita-n et al., Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa, Int J Cancer, vol.110, pp.907-913, 2004.

S. Z. , Caractéristiques épidémiologiques et biologiques de l'hépatite virale C, pp.26-29

A. Algiers, Association of Algerian Internist (AILA)

. Shepard-cw, A. Finelli-l, and . Mj, Global epidemiology of hepatitis C virus infection, Lancet Infect Dis, vol.5, pp.558-567, 2005.

. Sievert-w, R. Altraif-i, . Ha, A. Abdo-a, . Ea et al.,

, HIV and HCV infections in Africa and their impact on cancer General discussion 197

. Piratvisuth-t, . Sanai-fm, A. I. Sharara, . Sibbel-s, S. Sood-a et al., A systematic review of hepatitis C virus epidemiology in, 2011.

A. Asia and E. , Liver Int, vol.31, issue.2, pp.61-80

. Skinner-me, . Parkin-dm, . Vizcaino-ap, and . Ndhlovu-a, Cancer in the African Population of Bulawayo, Zimbabwe, 1963-1977. Incidence, Time Trends and Risk Factors, 1993.

. Spiga-s, Aménageurs et migrants dans les villes du Grand Sud algérien, Autrepart, vol.36, pp.81-103, 2005.

J. Sy-t and . Mm, Epidemiology of hepatitis C virus (HCV) infection, Int J Med Sci, vol.3, pp.41-46, 2006.

. Stoneburner-rl and . Low-beer-d, Population-level HIV declines and behavioral risk avoidance in Uganda, Science, vol.304, pp.714-718, 2004.

. Teguete-i, T. Muwonge-r, . Cb, . Dolo-a, . Bayo-s et al.,

R. , Can visual cervical screening be sustained in routine health services? Experience from Mali, Africa. BJOG, vol.119, pp.220-226

. Touaibia-r, A. Merbout-g, and B. M. Rapport, Rapport de Situation National à l'Intention de l'UNGASS sur le Suivi de la Déclaration d'Engagement de la Session Extraordinaire de l'Assemblée Générale des Nations Unies ( UNGASS ) sur le VIH / SIDA (Période considérée, 2008.

, Regional report on AIDS, 2011.

W. Unaids, Report on the global AIDS epidemic. UNAIDS WHO, 2008.

, HIV and HCV infections in Africa and their impact on cancer General discussion 198

. Undp and . Algeria, Country Profile: Human Development Indicators, UNDP, 2012.

, Human papillomavirus (HPV) vaccine background paper, pp.5-9, 2008.

. Who and . Obesity, Situation and trends, pp.28-40, 2012.

, WHO and ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers

S. Geneva and W. Ico, , 2010.

K. Chaabna, M. Boniol, D. Vuyst, H. Vanhems, P. et al., Geographical Patterns of Kaposi Sarcoma, Non-Hodgkin Lymphomas and Cervical Cancer Associated with HIV Infection in Five African Populations, European Journal of Cancer Prevention, vol.21, issue.1, pp.1-9, 2012.

K. Chaabna, I. Soerjomataram, S. Rouabhia, S. Chichoune, C. Scholtes et al., Co-occurrence of Diffuse Large B Cell Non-Hodgkin Lymphoma and Chronic Hepatitis C in Algerian Patients: Two Case Reports

K. Chaabna, F. Bray, H. R. Wabinga, E. Chokunonga, M. Borok et al., Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?, International Journal of Cancer, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00965786

K. Chaabna, Z. Boudiaf, P. Vanhems, S. Rouabhia, M. Laouar et al., Very late presentation of HIV/AIDS in Algeria: a need of increase awareness and early detection

S. Rouabhia, M. Sadelaoud, K. Chaabna, W. Toumi, and L. Abenavoli, Hepatitis C virus genotypes in eastern Algeria: a retrospective study, Accepted by World Journal of Hepatology, p.3, 2013.

K. Chaabna, R. Newton, P. Vanhems, M. Laouar, D. Forman et al., Allcause mortality in HIV-positive patients from six Algerian regions before and during HAART era, 2013.

K. Chaabna, I. Soerjomataram, P. Vanhems, D. Forman, and S. Bouzeghoub, HIV/AIDS national and regional trend and patient profile in Algeria from 1985 to, 2008.

K. Chaabna, I. Soerjomataram, F. Bray, H. R. Wabinga, E. Chokunonga et al., Trends in HIV prevalence and Kaposi sarcoma incidence in Africa. 48 th IARC scientific council, 2012.

K. Chaabna, F. Bray, H. Wabinga, E. Chokunonga, P. Vanhems et al., SP3-67 Kaposi sarcoma incidence in Uganda and Zimbabwe, before and during HIV/AIDS epidemic, Journal of Epidemiology and Community Health, 2011.

K. Chaabn, F. Bray, H. R. Wabinga, E. Chokunonga, M. Borok et al., Kaposi sarcoma incidence in Uganda and Zimbabwe before and during the HIV/AIDS epidemic. GRELL meeting, 2011.

K. Chaabna, M. Boniol, D. Vuyst, H. Vanhems, P. et al., Distribution Géographique du Sarcome de Kaposi, du Lymphome Non-Hodgkinien et du cancer du col de l'utérus associés à l'infection au VIH, dans cinq populations africaines en 1998-2002. V th National Days of Infectious Disease Prevention, 2011.

K. Chaabna, F. Bray, H. R. Wabinga, E. Chokunonga, M. Borok et al., Incidence du sarcome de Kaposi en Ouganda et au Zimbabwe avant et au cours de l'épidémie de VIH. V th National Days of Infectious Disease Prevention, 2011.

K. Chaabna, M. Boniol, D. Vuyst, H. Vanhems, P. et al., Geographical patterns of Kaposi sarcoma, non-Hodgkin lymphoma and cervical cancer associated with HIV infection in five African populations. 6 th Cancer Scientific Forum of the Cancerpôle CLARA, 2011.

K. Chaabna, F. Bray, H. R. Wabinga, E. Chokunonga, M. Borok et al., Kaposi sarcoma incidence in Uganda and Zimbabwe, before and during HIV/AIDS epidemic. 47 th IARC scientific council, 2011.

K. Chaabna, M. Boniol, D. Vuyst, H. Vanhems, P. et al., Geographical patterns of Kaposi sarcoma, non-Hodgkin lymphoma and cervical cancer associated with HIV infection in five African populations, Scientific BMIC Graduate School Days, 2010.

K. Chaabna, M. Boniol, D. Vuyst, H. Vanhems, P. et al., Distribution Géographique du Sarcome de Kaposi, du Lymphome Non-Hodgkinien et du cancer du col de l'utérus associes a l'infection au VIH, dans cinq populations africaine en 1998-2002, IV th International Congress of Epidemiology «Du Nord au Sud» by ADELF (Association des Epidémiologistes de Langue Française), 2010.

, HIV and HCV infections in Africa and their impact on cancer Products of the thesis work, p.203

K. Chaabna, M. Boniol, D. Vuyst, H. Vanhems, P. et al., Distribution Géographique du Sarcome de Kaposi, du Lymphome Non-Hodgkinien et du cancer du col de l'utérus associes a l'infection au VIH, dans cinq populations africaine en 1998-2002, IV th International Congress of Epidemiology «Du Nord au Sud» / Revue d'Épidémiologie et de Sante Publique 58S, pp.51-98, 2010.